This is an old revision of the document!
Dr. Nemunitis is one of the leading investigators for developing early-phase trials aimed at identifying new cancer-specific therapies administered in an outpatient setting. Dr. Nemunaitis is active in accelerating the bench to bedside process for HIBM gene therapy.
Dr. Nemunaitis completed his medical school training at Case Western Reserve University,Cleveland, OH in 1982,